000103 PACLITAXEL-CARBOPLATIN-GEMCITABINE VS. PACLITAXEL-CARBOPLATIN AS FIRSTLINE TREATMENT OF OVARIAN CANCER: A RANDOMIZED PHASE III GCIG INTERGROUP STUDY (AGO-OVAR 9, GINECO-TCG, NSGO-OC-0102)
du Bois, A., Schroeder, W., Jelic, S., Weber, B., Sehouli, J., Keern, J., Priou, F., Huober, J., Railing, M., Ray-Coquard, I., Heilmann, V., Surges, A., Pfisterer, J., Gropp, M., Staehle, A., Wimberger, P., Jackisch, C., Mueller, H. H.
Published in International journal of gynecological cancer (01.09.2005)
Published in International journal of gynecological cancer (01.09.2005)
Get full text
Journal Article
PACLITAXEL-CARBOPLATIN-GEMCITABINE VS. PACLITAXEL-CARBOPLATIN AS FIRSTLINE TREATMENT OF OVARIAN CANCER: A RANDOMIZED PHASE III GCIG INTERGROUP STUDY (AGO-OVAR 9, GINECO-TCG, NSGO-OC-0102): 000103
du Bois, A, Schroeder, W, Jelic, S, Weber, B, Sehouli, J, Keern, J, Priou, F, Huober, J, Railing, M, Ray-Coquard, I, Heilmann, V, Surges, A, Pfisterer, J, Gropp, M, Staehle, A, Wimberger, P, Jackisch, C, Mueller, H H
Published in International journal of gynecological cancer (01.09.2005)
Get full text
Published in International journal of gynecological cancer (01.09.2005)
Journal Article